Research case studies Explore a selection of reports that spotlight particular areas of research at the Crick over the past five years.
Vacancies Find links to current vacancies, and information about recruitment to various types of role. Discover job opportunities at the Crick.
Breadcrumb Research Topics Biochemistry & Proteomics Equipment in the Mass Spectrometry Proteomics Science Technology Platform. Toggle to view hero caption IntroA wide variety of biochemical and proteomic approaches are used to understand the complex molecules and their interactions underlying the biological processes at work in our cells and tissues. Research groups Dimitrios Anastasiou Cancer Metabolism Laboratory David Balchin Protein Biogenesis Laboratory Kate Bishop Retroviral Replication Laboratory Mike Blackman Malaria Biochemistry Laboratory Simon Boulton DSB Repair Metabolism Laboratory Luiz Pedro Carvalho Mycobacterial Metabolism and Antibiotic Research Laboratory Peter Cherepanov Chromatin Structure and Mobile DNA Laboratory Alessandro Costa Macromolecular Machines Laboratory Bart de Strooper | Lorena Arancibia Cellular Phase of Alzheimer’s Disease Laboratory Erika Alden DeBenedictis Biodesign Laboratory John Diffley Chromosome Replication Laboratory Radoslav Enchev Visual Biochemistry Laboratory Fermentation Fabian Fröhlich Dynamics of Living Systems Laboratory Sergi Garcia Manyes Single Molecule Mechanobiology Laboratory Jeannine Hess Biological Inorganic Chemistry Laboratory Neil McDonald Signalling and Structural Biology Laboratory Charlie McTernan Artificial Molecular Machinery Laboratory Michele Mishto Molecular Immunology Laboratory Francesca Ester Morreale Targeted Protein Degradation and Antibiotic Research Laboratory Pagination Current page 1 Page 2 Next page Next Last page Last Science Technology Platforms Chemical Biology Metabolomics Proteomics Related content Introducing...Francesca Ester Morreale 11 April 2023 New method to label proteins could help track disease Type: News 25 October 2022 Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery Type: News 2 April 2021 New proteomic technology accelerates COVID-19 biomarker and exploratory drug discovery Type: News 25 March 2021 Share the page Share on Twitter Share on Facebook Share on LinkedIn Share on Email
Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery Type: News 2 April 2021
New proteomic technology accelerates COVID-19 biomarker and exploratory drug discovery Type: News 25 March 2021
